Brian Scanlan

Brian Scanlan General Information

Biography

Mr. Brian Scanlan is the Founder and serves as a Managing Partner at Freedom Bioscience Partners. Mr. Brian Scanlan serves as Operating Partner, Life Sciences at Edgewater Capital Partners. He served as President and Chief Executive Officer at Cambridge Major Laboratories. He serves as a Board Member at Haematologic Technologies. Hw is responsible for developing and implementing corporate development strategies for the company, including sales and marketing, planning & forecasting, contracts & legal issues, and project management. He brings significant industry experience in creating deals tailored to the client's specific needs and has been involved in several pharmaceutical contract chemistry organizations over the past fifteen years ranging from startups to large CMOs. Before joining the company, He managed business development activities in North America for Rhodia ChiRex focusing on the emerging pharmaceutical and biotech sectors. In addition, he managed the company's chiral technology portfolio and was instrumental in creating the company's chiral chromatography business. Before Rhodia ChiRex, he helped form the startup company, Universal Pharma Technologies, where he was responsible for all sales and marketing efforts. He started his career with petrochemical giant UOP where he was an R&D chemist, then later moved into the specialty chemicals group in various marketing roles. He currently serves on the Board of Directors of the Wisconsin Biotechnology and Medical Device Association and is active in several industry organizations. He has earned his BS in Chemistry from Northern Illinois University, and his MBA from the Stuart School of Business of Illinois Institute of Technology.